Brainstorm Cell Therapeut...

NASDAQ: BCLI · Real-Time Price · USD
0.60
0.00 (0.00%)
At close: Aug 15, 2025, 12:41 PM

Brainstorm Cell Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-11.62M -17.19M -24.28M -24.46M
Depreciation & Amortization
240K 265K 285K 260K
Stock-Based Compensation
750K n/a 1.68M 1.37M
Other Working Capital
160K -3.75M -601K -2.05M
Other Non-Cash Items
-147K 220K -1.34M n/a
Deferred Income Tax
n/a n/a 1.34M n/a
Change in Working Capital
1.69M -3.75M 2.99M -3.43M
Operating Cash Flow
-9.09M -20.46M -19.32M -26.27M
Capital Expenditures
n/a -18K -29K -330K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a 2.21M 1.03M n/a
Other Investing Acitivies
12K n/a n/a 653K
Investing Cash Flow
12K 2.19M 998K 323K
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a 5K
Financial Cash Flow
7.97M 18.98M 238K 6.97M
Net Cash Flow
-1.11M 713K -18.08M -18.97M
Free Cash Flow
-9.09M -20.48K -19.35M -26.59M